Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00841724
PHASE2

Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

The goal of this prospective study is to assess the overall mortality (whether related to relapse/progression or toxicity - TRM-) at one year after allogeneic stem cell transplantation prepared by a so-called reduced-toxicity "submyeloablative" conditioning regimen in patients with hematological malignancies.

Official title: Phase II Study of a Reduced-toxicity " Submyeloablative " Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

82

Start Date

2009-01

Completion Date

2012-01

Last Updated

2026-09-14

Healthy Volunteers

No

Interventions

DRUG

Fludarabine, Busulfan, Thymoglobuline

Locations (3)

Institut Paoli Calmettes

Marseille, France

CHU de Nantes

Nantes, France

CHU de Bordeaux

Pessac, France